Gain Therapeutics, Inc. - Common Stock — 재무제표 (NASDAQ:GANX) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 38.99 M24.1 M18.61 M12.12 M22.82 M 총 부채 4.17 M5.22 M6.03 M4.78 M4.25 M 자본금 총액 34.82 M18.88 M12.58 M7.34 M18.56 M 총 부채 및 주주자본 38.99 M24.1 M18.61 M12.12 M22.82 M 총부채 590.47 K495.26 K449.05 K328.33 K400.95 K 순부채 590.47 K495.26 K-16.35 M328.33 K-20.54 M

뉴스

파킨슨병 바이오마커 81% 감소 보고 - Gain Therapeutics

Gain Therapeutics reports 81% reduction in Parkinson’s biomarker

Why GH Research Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket - BioAtla (NASDAQ:BCAB), ChowChow Cloud Internatio (AMEX:CHOW)

Gain Therapeutics (GANX) Upgraded to Buy: Here's Why

Roth/MKM, Gain Therapeutics 목표 주가 17,000원으로 상향

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.14%

Is Enhabit, Inc. (EHAB) Stock Outpacing Its Medical Peers This Year?

Here's Why Gain Therapeutics, Inc. (GANX) is a Great Momentum Stock to Buy

게인 테라퓨틱스, 임상 데이터 발표 앞두고 ’매수’ 등급 유지

H.C. Wainwright reiterates Buy rating on Gain Therapeutics stock ahead of trial data

게인 테라퓨틱스, 3550만 달러 규모의 주식 공모 추가 설명서 제출

Gain Therapeutics files prospectus supplement for $35.5 million stock offering